Quốc gia: Vương quốc Anh
Ngôn ngữ: Tiếng Anh
Nguồn: VMD (Veterinary Medicines Directorate)
Garlic, Garlic Oil
Dorwest Herbs Limited
Garlic, Garlic Oil
Coated tablet
AVM-GSL - Authorised Veterinary Medicine – General Sales List
Cats, Dogs
Herbal
Expired
1997-09-01
Revised: December 2019 AN: 01138/2019 Page 1 of 4 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Garlic Sugar Coated Tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active substances: Each tablet contains; Garlic ( Powdered) 30mg Oil of Garlic 0.001ml Excipients: Titanium dioxide (E171) 0.15mg For full list of excipients see section 6.1 3. PHARMACEUTICAL FORM Coated tablet White sugar coated tablet, 8.73mm diameter 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs and cats 4.2 INDICATIONS FOR USE A herbal medicine for the symptomatic relief of coughs and bronchial conditions, and an aid to maintaining general health in dogs and cats. 4.3 CONTRA-INDICATIONS None 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Dogs – None necessary Cats – None necessary Revised: December 2019 AN: 01138/2019 Page 2 of 4 4.5 SPECIAL PRECAUTIONS FOR USE i) Special precautions for use in animals: If condition fails to improve within 7 days, consult a veterinary surgeon ii) Special precautions to be taken by the person administering the medicinal product to animals: Wash hands after use 4.6 ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS) Based on post marketing experience and complementary data, emesis has been observed very rarely. The frequency of adverse reactions is defined using the following convention: - very common (more than 1 in 10 animals treated displaying adverse reaction(s)) - common (more than 1 but less than 10 animals in 100 animals treated) - uncommon (more than 1 but less than 10 animals in 1,000 animals treated) - rare (more than 1 but less than 10 animals in 10,000 animals treated) - very rare (less than 1 animal in 10,000 animals treated, including isolated reports). 4.7 USE DURING PREGNANCY AND LACTATION Normal use, no restrictions 4.8 INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF INTERACTION None known 4.9 AMOUNTS TO BE ADMINISTERED AND ADMINISTRATION ROUTE 1 tablet per 5kgs bodyweight daily Oral administration 4.10 OVERDOSE No treatment specified 4.11 WITHDRAWAL PE Đọc toàn bộ tài liệu